Niels C. Riedemann
Inflarx (Germany)(DE)
Publications by Year
Research Areas
Complement system in diseases, Sepsis Diagnosis and Treatment, COVID-19 Clinical Research Studies, Immune Response and Inflammation, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Novel strategies for the treatment of sepsis(2003)774 cited
- → The enigma of sepsis(2003)563 cited
- → New Approaches to Sepsis: Molecular Diagnostics and Biomarkers(2012)532 cited
- → The late phase of sepsis is characterized by an increased microbiological burden and death rate(2011)437 cited
- → Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression(2003)323 cited
- → Generation of C5a by Phagocytic Cells(2002)209 cited
- → Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial(2020)199 cited
- → Increased C5a receptor expression in sepsis(2002)193 cited
- → Liver Dysfunction and Phosphatidylinositol-3-Kinase Signalling in Early Sepsis: Experimental Studies in Rodent Models of Peritonitis(2012)180 cited